Sign in with Google
bullish
IMNN: First Site Activated for Phase 3 OVATION 3 Trial
On May 12, 2025, Imunon, Inc. (IMNN) announced financial results for the first quarter of 2025 and provided a business update. The company...
What is covered in the Full Insight:
- Business Update
- Phase 3 OVATION 3 Trial Activation
- Phase 2 OVATION 2 Trial Results
- Statistical Design and Regulatory Approval
- Financial Overview and Market Valuation
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Zhejiang Sanhua Intelligent Controls (2050 HK): Big Raise Supported by Cornerstones
- [Japan M&A] Hino & Mitsubishi-Fuso Truck to Join; Bagholding Ugly for Minorities, and a Re-IPO
- Zhejiang Sanhua Intelligent Controls A/H Listing - Relatively Large but Digestible
- New World Resources (NWC AU)'s Possible Interloper
- More Accurate Context Behind Tencent’s Nexon Moves Reported by Bloomberg
Top Unpaywalled Insights
More »- China A-Share Consumer Staples: An Analysis of the Opportunities Ahead
- Bearishness Persist in Soybeans Despite Rebound Hopes
- Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
- [IO Technicals 2025/23] Bearish Momentum Persists
- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
Discussions
(Paid Plans Only)
x